000 | 01990 a2200577 4500 | ||
---|---|---|---|
005 | 20250516013955.0 | ||
264 | 0 | _c20110823 | |
008 | 201108s 0 0 eng d | ||
022 | _a1878-5492 | ||
024 | 7 |
_a10.1016/j.trim.2010.11.006 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGe, Shili | |
245 | 0 | 0 |
_aImmunologic parameters and viral infections in patients desensitized with intravenous immunoglobulin and rituximab. _h[electronic resource] |
260 |
_bTransplant immunology _cApr 2011 |
||
300 |
_a142-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAlemtuzumab |
650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _ximmunology |
650 | 0 | 4 |
_aAntibodies, Neoplasm _ximmunology |
650 | 0 | 4 |
_aB-Lymphocytes _xmetabolism |
650 | 0 | 4 |
_aCytomegalovirus Infections _xdrug therapy |
650 | 0 | 4 | _aDaclizumab |
650 | 0 | 4 |
_aDesensitization, Immunologic _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGraft Rejection _xprevention & control |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin G _ximmunology |
650 | 0 | 4 |
_aImmunoglobulins _xblood |
650 | 0 | 4 |
_aImmunoglobulins, Intravenous _ximmunology |
650 | 0 | 4 | _aKidney Transplantation |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMonitoring, Immunologic |
650 | 0 | 4 | _aRituximab |
650 | 0 | 4 |
_aT-Lymphocytes _xmetabolism |
700 | 1 | _aPao, Andy | |
700 | 1 | _aVo, Ashley | |
700 | 1 | _aDeer, Nathan | |
700 | 1 | _aKarasyov, Artur | |
700 | 1 | _aPetrosyan, Anna | |
700 | 1 | _aKahwaji, Joseph | |
700 | 1 | _aLukovsky, Marina | |
700 | 1 | _aChai, Ning-Ning | |
700 | 1 | _aAguiluz, Angela | |
700 | 1 | _aMirocha, James | |
700 | 1 | _aJordan, Stanley C | |
700 | 1 | _aToyoda, Mieko | |
773 | 0 |
_tTransplant immunology _gvol. 24 _gno. 3 _gp. 142-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.trim.2010.11.006 _zAvailable from publisher's website |
999 |
_c20414705 _d20414705 |